Chrysos Corporation (ASX: C79) to Announce FY26 Financial Results and Host Investor Webcast on 11 August 2026

Chrysos Corporation’s Role in the Global Mining Technology Market

Operating as a science and software-driven technology company, Chrysos Corporation Limited focuses on delivering cutting-edge solutions to the global mining sector. Based in Adelaide with international operations, the company specialises in rapid mineral analysis technology. Its core business involves licensing and deploying proprietary platforms to mining operators seeking faster, safer, and more environmentally sustainable analytical methods. This aligns with the broader industry trend toward automation and digitisation in mineral processing and exploration.

Extending beyond South Australia, Chrysos has successfully commercialised its technology across multiple mining jurisdictions. By integrating scientific expertise with software innovation, the company has established a competitive niche in mining services technology. The upcoming full year results will offer investors insight into Chrysos’s progress in scaling technology adoption globally and its financial performance within this competitive sector.

Overview of PhotonAssay Technology and Product Suite

PhotonAssay is Chrysos Corporation’s flagship technology platform, providing faster, safer, more accurate, and environmentally friendly analysis of key mining elements such as gold, silver, and copper. Its multi-element analysis capability broadens the company’s addressable market by serving diverse mining commodities and exploration scenarios. The technology’s focus on speed, safety, accuracy, and environmental benefits meets growing industry demands for efficient and sustainable mining practices.

The PhotonAssay product line represents the commercial outcome of Chrysos’s significant R&D investment in advanced analytical technologies. Combining hardware innovation with software platforms, the company potentially generates recurring revenues through software licensing or subscriptions. For mining operators, this technology enables improved decision-making in exploration and processing, reducing operational costs and enhancing project economics. Environmental advantages also position PhotonAssay favourably amid increasing stakeholder pressure for sustainable mining.

Scheduled FY26 Full Year Financial Results Announcement on 11 August 2026

Chrysos Corporation will disclose its full year financial results for the year ended 30 June 2026 on Tuesday, 11 August 2026. This announcement will include detailed financial performance metrics such as revenue, operating expenses, profitability, and cash position over the 12-month period. It marks a key milestone in the company’s investor calendar, providing shareholders and market participants with comprehensive insights into financial trends, operational achievements, and capital status. The timing enables comparison against prior years and evaluation of technology adoption and revenue growth.

As an ASX-listed entity, Chrysos’s full year results fulfill regulatory obligations and offer transparency on financial health and strategic progress. The release will typically feature management’s discussion and analysis of operational performance, sector-relevant KPIs, and forward-looking commentary from the board and executives. Investors monitoring the company’s commercialisation and financial sustainability will gain critical data to assess its competitive positioning in mining technology.

Executive Webcast and Conference Call at 10:30 am AEST

Following the FY26 results release, CEO Dirk Treasure and CFO Brett Coventry will host a live webcast and conference call at 10:30 am AEST on 11 August 2026. This session offers analysts and investors direct access to senior management for detailed discussion, clarifications, and insights into strategic priorities. The joint participation of CEO and CFO ensures comprehensive coverage of operational and financial aspects, allowing exploration of business strategy, financial metrics, capital allocation, and guidance.

The dual webcast and conference call format reflects best practices in investor relations, accommodating diverse geographic locations and communication preferences. The webcast enables visual presentation of results and charts, while the conference call facilitates interactive Q&A. Scheduled during Australian business hours, the timing also suits European and North American participants, maximizing global accessibility.

Investor Registration and Access Details

Chrysos Corporation has provided registration links for investors and analysts to access the FY26 results announcement webcast and conference call. The webcast is accessible via OpenBriefing at https://webcast.openbriefing.com/c79-fyr-2026/, while conference call registration is available at https://registrations.events/direct/MCM994209. Registrants will receive confirmation and connection details ahead of the 10:30 am AEST start on 11 August 2026. Utilizing established third-party platforms ensures professional delivery and technical reliability.

Participants should register through these links to obtain dial-in credentials, webcast access, and any supplementary materials. Chrysos has engaged Sodali & Co. as its investor relations partner, with contacts Paul Ryan and Annalise Batchelor available for inquiries related to the results, registration, or investment matters. This structured communication approach aligns with ASX-listed company standards, promoting transparency and accessibility.

Adelaide Headquarters and International Operations

Chrysos Corporation is headquartered at 2A Venture Road, Tonsley, Adelaide, South Australia, situating it within a prominent technology and advanced manufacturing precinct. This location integrates the company within a supportive innovation ecosystem. Beyond its headquarters, Chrysos operates globally, reflecting successful international commercialisation of PhotonAssay technology and establishment of sales, support, and operational infrastructure worldwide. This global footprint underscores the company’s ambition to serve mining operations across multiple jurisdictions and highlights the broad applicability of its analytical solutions.

Operating in diverse geographic markets exposes Chrysos to various mining commodity cycles, exploration trends, and regulatory environments. While presenting opportunities through access to large markets and diverse customers, it also introduces complexities such as currency risk, multi-jurisdictional compliance, and logistical challenges. The FY26 results are expected to shed light on revenue distribution by region, market performance, and strategic priorities for further international expansion.

Mining Technology Industry Trends and Demand Drivers

The mining sector continues to demand technologies that enhance operational efficiency, reduce costs, and improve environmental and safety outcomes. PhotonAssay addresses these priorities by enabling faster analysis, improving accuracy, reducing environmental impact, and enhancing safety compared to traditional assay methods. These benefits align with industry trends toward automation, digitisation, sustainability, and workforce safety. Chrysos’s positioning suggests it benefits from structural tailwinds favoring advanced analytical technologies.

With its multi-element analysis capability covering gold, silver, copper, and other elements, Chrysos serves multiple commodity markets, mitigating reliance on any single cycle. As mining companies face pressures to boost productivity, lower environmental footprints, and manage labour constraints, technology-driven automation and enhanced analytics become increasingly vital. The FY26 results will provide insight into market adoption momentum and revenue growth, with investor focus on management’s commentary regarding industry receptiveness and commercial deployment opportunities.

FY26 Financial Performance and Capital Status

The FY26 full year results will reveal Chrysos Corporation’s financial performance, including revenue, operating costs, profitability, and cash reserves as of 30 June 2026. These metrics are crucial for evaluating financial sustainability, growth prospects, and capital adequacy to support ongoing operations and technology development. Investors typically assess revenue growth, customer acquisition and retention, gross margins, and cash burn rates relative to reserves. The results will indicate progress toward profitability or sustainable positive cash flow.

Given the capital-intensive nature of technology development, the announcement will provide insights into capital allocation, R&D investment, sales and operational expansion, and strategic partnerships aimed at accelerating PhotonAssay commercialisation. Commentary on customer acquisition costs, lifetime value, and customer base growth will offer further perspective on business model scalability and sustainability. The FY26 disclosure is key to assessing whether Chrysos’s financial trajectory supports its long-term ambitions in mining technology.

Investor Engagement and Market Impact Outlook

The FY26 results announcement on 11 August 2026, followed by the webcast and conference call, represents a significant investor engagement event and potential catalyst for share price movement. Market reaction will depend on how reported results compare with analyst expectations and management’s guidance on growth prospects. Investors should closely monitor the announcement and management discussion for insights into operational trends, market opportunities, competitive positioning, and capital deployment.

Prior to the announcement, share price impact remains uncertain. Post-release movements will reflect investor interpretation of financial metrics, quality of guidance, and broader mining technology sector sentiment. The webcast and conference call provide a valuable forum for direct dialogue with management, reducing information asymmetry and supporting informed investment decisions. Investors are encouraged to review the full year results and management commentary to gain comprehensive understanding of Chrysos Corporation’s financial health and strategic direction.